Danasupra Erapacific Tbk. vs Suparma Tbk. — how do they compare? Danasupra Erapacific Tbk. trades at Rp105 (market cap 72.85B, 10.82M 24h volume), while Suparma Tbk. trades at Rp168 (market cap 688.85B, 577.3K 24h volume). The key difference: Suparma Tbk. is far larger — about 9.5× Danasupra Erapacific Tbk.'s market cap, and Danasupra Erapacific Tbk. is more actively traded (10.82M versus 577.3K). Which is the better fit depends on your goals.
| DEFI | SPMA | |
|---|---|---|
Market Cap | 72.85B | 688.85B |
Volume | 10.82M | 577.3K |
Lot | 108.22K | 5.77K |
Turnover | 1.14B | 96.54M |
Average Price | 105.37 | 167.22 |
Value | 1.14B | 96.54M |
Indicative Equilibrium Price | 105 | 168 |
Indicative Equilibrium Volume | 5.42K | 37 |
Trailing returns across standard periods
Latest headlines on both assets
Danasupra Erapacific Tbk PT. (The "Company") was established by notarial act Elliza, SH. no 65 dated 11 November 1994. Articles of the company has been approved by the Ministry of Justice of the Republic of Indonesia in its Decision Letter. C2-1.101.HT.01.01.Th.95 dated January 25, 1995. Based on the Notary Act Refizal, SH. 12, dated January 18, 2000 the company made changes to the status of the company closed to open company, authorized capital, change in nominal value of shares and public offering through the stock market. Articles of Association was approved by the Minister of Law and Legislation of the Republic of Indonesia in its Decision Letter. C-1248.HT.01.04.Th.2000 dated February 3, 2000.Accordance with Article 3 Articles of Association, the scope of its business is run financing activities which include consumer finance, factoring and leasing.
Read more on DEFI →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →